Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
Saved in:
| Title: | Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study. |
|---|---|
| Authors: | Sharman JP; a Willamette Valley Cancer Institute and Research Center , US Oncology Research , Eugene , OR , USA., Forero-Torres A; b University of Alabama School of Medicine , Birmingham , AL , USA., Costa LJ; c Division of Hematology/Oncology , Medical University of South Carolina , Charleston , SC , USA., Flinn IW; d Sarah Cannon Research Institute , Nashville , TN , USA., Inhorn L; e Blue Ridge Cancer Care , Roanoke , VA , USA., Kelly K; f USC Norris Comprehensive Cancer Center , Los Angeles , CA , USA., Bessudo A; g California Cancer Associates for Research and Excellence , San Diego , CA , USA., Fayad LE; h Department of Lymphoma and Myeloma , M.D. Anderson Cancer Center, University of Texas , Houston , TX , USA., Kaminski MS; i Division of Hematology/Oncology , University of Michigan Comprehensive Cancer Center, Ann Arbor , MI , USA., Evens AM; j Rutgers Cancer Institute of New Jersey , New Brunswick , NJ , USA., Flowers CR; k Winship Cancer Institute , Atlanta , GA , USA., Sahin D; l F. Hoffmann-La Roche Ltd , Basel , Switzerland., Mundt KE; l F. Hoffmann-La Roche Ltd , Basel , Switzerland., Sandmann T; m Genentech Inc. , South San Francisco , CA , USA., Fingerle-Rowson G; l F. Hoffmann-La Roche Ltd , Basel , Switzerland., Vignal C; l F. Hoffmann-La Roche Ltd , Basel , Switzerland., Mobasher M; m Genentech Inc. , South San Francisco , CA , USA., Zelenetz AD; n Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center , New York , NY , USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2019 Apr; Vol. 60 (4), pp. 894-903. Date of Electronic Publication: 2018 Oct 02. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2018.1515940 |
